Back to School: How biopharma can reboot drug development. Access exclusive analysis here
BIIB said that no confirmed cases of progressive multifocal leukoencephalopathy (PML) had been reported in patients receiving Tysabri
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury